Results 131 to 140 of about 36,696 (303)

Evaluation of %CV and average glucose derived from pre‐ and postprandial 6‐point glucose measurements for assessing hypoglycemia risk

Journal of Diabetes Investigation, EarlyView.
Six‐point pre‐ and postprandial glucose values were extracted from CGM to calculate average glucose and %CV. ROC analysis identified AG <167.7 mg/dL and %CV >21.6% as key risk factors, enabling simple detection of high hypoglycemia risk using limited glucose measurements. ABSTRACT Aims/Introduction This study determined the usefulness of coefficient of
Rika Soga, Keiichi Torimoto, Fumi Uemura, Yosuke Okada, Shingo Nakayamada   +4 more
wiley   +1 more source

Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novelKCNJ11mutation [PDF]

, 2015
Sung Yeon Ahn, Gu-Hwan Kim, Han‐Wook Yoo   +2 more
openalex   +1 more source

Impact of renal function on antidiabetic drug selection in Japan: A real‐world analysis using the J‐DREAMS database

Journal of Diabetes Investigation, EarlyView.
Using a large Japanese real‐world database, we examined antidiabetic drug selection in first and second therapy stratified by renal function and study period. The earlier initiation of SGLT2 inhibitors and GLP‐1 receptor agonists increased over time, particularly in second therapy, with prescribing patterns increasingly aligned across renal function ...
Masashi Kubota, Mitsuru Ohsugi, Kohjiro Ueki   +2 more
wiley   +1 more source

Chronic Microvascular Complications in Sulfonylureas-Treated Diabetic Patients: Correlations with Glycemic Control, Risk Factors and Duration of the Disease

Clinics and Practice
Background: Diabetes has become one of the most challenging public health problems due to the alarming increase in prevalence and the morbidity and mortality attributed to its acute and chronic complications.
Luminita-Georgeta Confederat, Roxana Stefan, Mihaela-Iustina Condurache, Oana-Maria Dragostin   +3 more
doaj   +1 more source

Oral Hypoglycemic Agents [PDF]

, 1977
In conclusion, comment is made on the findings of the University Group Diabetes Program (UGDP). The purpose of the UGDP was to determine whether or not control of blood glucose levels would help to prevent or delay vascular disease in non-insulin ...
Rifkin, Harold
core   +1 more source

Association of glucagon‐like peptide‐1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes

Journal of Diabetes Investigation, EarlyView.
This TriNetX (US, 2016–2023) study compared clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes treated with GLP‐1 receptor agonists vs DPP4 inhibitors. ABSTRACT Objectives To evaluate whether glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are associated with improved survival and renal outcomes in patients with ...
Yu‐Ting Yu, Ying Chun Lee, Yu‐Wei Fang, Wen‐Hui Hsieh, Ming‐Hsien Tsai   +4 more
wiley   +1 more source

Aminoácidos como recuperadores de plantas de milho intoxicadas por nicosulfuron. [PDF]

, 1915
bitstream/item/25039/1/0027 ...
SILVA, J. A. A. da, COELHO, A. M., GAZZIERO, D. L. P., VARGAS, L., KARAM, D.   +4 more
core  

Sulfonylurea receptors set the maximal open probability, ATP sensitivity and plasma membrane density of K_ATP channels [PDF]

, 1999
Andrey P. Babenko, Gabriela González, Lydia Aguilar‐Bryan, Joseph Bryan   +3 more
openalex   +1 more source

Five‐year follow‐up of incretin‐based therapy in a patient with KCNJ11‐related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction

Journal of Diabetes Investigation, EarlyView.
In a woman with KCNJ11‐related permanent neonatal diabetes mellitus, incretin‐based therapy enabled insulin discontinuation and maintained glycemic control for more than 5 years, with HbA1c between 6.1% and 6.5% on the lowest semaglutide dose, dose‐dependent improvement in insulin secretion, and an approximately 60% reduction in glibenclamide dose ...
Toshiaki Ohkuma, Ryoichiro Aotani, Wakako Sakamoto, Ayaka Oshiro, Tetsuro Ago   +4 more
wiley   +1 more source

Weight Gain in Type 2 Diabetes Mellitus Patients Receiving Sulfonylurea Medications at a Tertiary Hospital in Surabaya, Indonesia

Current Internal Medicine Research and Practice Surabaya Journal
Introduction: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by persistent hyperglycemia. The prevalence of diabetes in Indonesia is 1.5%, although East Java recorded a 2.1% rate in 2013.
Ghagat Dresta Putra Respati, Jongky Hendro Prajitno, Rosy Setiawati, Rio Wironegoro   +3 more
doaj   +1 more source